13D Filing: Black Horse Capital LP and Humanigen Inc (HGEN)

Page 1 of 8

Humanigen Inc (NASDAQ:HGEN): Dale Chappell’s Black Horse Capital LP filed an amended 13D.

You can check out Black Horse Capital LP’s latest holdings and filings here.

Please follow Black Horse Capital LP (if you aren’t already doing so) to get real-time email alerts whenever we publish an article about Black Horse Capital LP or update its stock holdings.

Follow Dale Chappell's Black Horse Capital

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
Black Horse Capital 5,996,710 0 5,996,710 0 5,996,710 5.6%
Black Horse Capital Master Fund Ltd 0 13,997,832 0 13,997,832 13,997,832 13.1%
Cheval Holdings, Ltd 0 46,876,309 0 46,876,309 46,876,309 43.9%
Black Horse Capital Management 52,873,019 0 52,873,019 0 52,873,019 49.5%
Dale Chappell 0 66,870,851 0 66,870,851 66,870,851 62.6%

Page 1 of 8 – SEC Filing


SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549
SCHEDULE 13D
(RULE 13D – 101)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2(a)
(Amendment No. 2)*
Humanigen, Inc.
(Name of Issuer)
Common Stock, par value $0.001
(Title of Class of Securities)
444863 10 4
(CUSIP Number)
Eric S. Wagner, Esq.
Kleinberg, Kaplan, Wolff & Cohen, P.C.
551 Fifth Avenue, New York, New York 10176
(212) 986-6000
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
February 27, 2018
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box [ ].
Note:  Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See Rule 13d-7 for other parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Follow Humanigen Inc (NASDAQ:HGEN)


Page 1 of 8